美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

FTD Companies Inc.

0.1740

0.0000

成交量：- -

成交额：- -

市值：492.81万

市盈率：-0.02

高：0.1740

开：0.1740

低：0.1740

收：0.1740

52周最高：6.03

52周最低：0.1313

股本：2,832.26万

流通股本：1,237.10万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-8.0341

每股收益(LYR):-8.0341

净资产收益率：--

总资产收益率：--

市净率：-3.52

市盈率(LYR):-0.02

数据加载中...

总览公司新闻资讯公告

美纳里尼集团药物艾拉司群获FDA优先审查资格

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/FTD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTD\",,,,,undefined,":{"symbol":"FTD","market":"US","secType":"STK","nameCN":"FTD Companies Inc.","latestPrice":0.174,"timestamp":1561492800000,"preClose":0.174,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":12371021,"shares":28322610,"eps":-8.034069,"marketStatus":"休市中","change":0,"latestTime":"06-25 16:00:00 EDT","open":0.174,"high":0.174,"low":0.174,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-8.034069,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1381377600000,"exchange":"NASDAQ","adjPreClose":0.174,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTD\",,,,,undefined,":{"symbol":"FTD","floatShares":12371021,"roa":"--","roe":"--","lyrEps":-8.034069,"shares":28322610,"dividePrice":0,"high":0.174,"amplitude":0,"preClose":0.174,"low":0.174,"week52Low":0.1313,"pbRate":"-3.52","week52High":6.03,"institutionHeld":0,"latestPrice":0.174,"eps":-8.034069,"divideRate":0,"volume":0,"delay":0,"ttmEps":-8.034069,"open":0.174,"prevYearClose":0.174},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-03-14","symbol":"FTD","fiscalQuarterEnding":"2018/12","expectedEps":-0.25,"name":null,"time":"","type":"earning","dateTimestamp":1552536000000,"reportTimeType":"","actualEps":-0.54},{"market":"US","date":"2018-11-07","symbol":"FTD","fiscalQuarterEnding":"2018/09","expectedEps":-0.2,"name":null,"time":"盘后","type":"earning","dateTimestamp":1541566800000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2018-08-08","symbol":"FTD","fiscalQuarterEnding":"2018/06","expectedEps":0.18,"name":null,"time":"盘后","type":"earning","dateTimestamp":1533700800000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2018-05-08","symbol":"FTD","fiscalQuarterEnding":"2018/03","expectedEps":0.22,"name":null,"time":"盘后","type":"earning","dateTimestamp":1525752000000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2018-04-02","symbol":"FTD","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1522641600000,"reportTimeType":"","actualEps":0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2259747416","title":"美纳里尼集团药物艾拉司群获FDA优先审查资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2259747416","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2259747416?lang=zh_cn&edition=fundamental","pubTime":"2022-08-13 01:41","pubTimestamp":1660326060,"startTime":"0","endTime":"0","summary":"FDA已批准该申请获优先审查，并指定2023年2月17日为PDUFA日期。美纳里尼集团首席执行官Elcin Barker Ergun表示：\"FDA接受我们的NDA申请并授予优先审查资格，这对我们公司而言是在监管方面取得的一个重要里程碑。我们期待着在FDA审查期间与其合作。美纳里尼集团现在全面负责艾拉司群的全球注册、商业化和进一步开发活动。2018年，艾拉司群获得美国食品药品监督管理局授予的快速通道资格。研究中的患者随机接受艾拉司群或研究人员所选择的经批准激素制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3842473_ZH42473_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4195","MAA","BK4215","FTD","PFS","RDUS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}